Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance
Wenxia Xu, Bingluo Zhou, Xiaoya Zhao, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 9, pp. 1122-1132
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance
Yuan Li, Zhiyuan Xu, Shanming Ruan, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 266
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways
Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154411-154411
Closed Access | Times Cited: 56
Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis
Bin Zhang, Jie Li, Yijun Wang, et al.
Cell Death and Differentiation (2024) Vol. 31, Iss. 3, pp. 309-321
Open Access | Times Cited: 15
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma
Magdalena Kuras, Lázaro Betancourt, Runyu Hong, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 832-832
Open Access | Times Cited: 1
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 42
The role and prospect of lysine‐specific demethylases in cancer chemoresistance
Yingqi Song, Guan‐Jun Yang, Dik‐Lung Ma, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1438-1469
Closed Access | Times Cited: 17
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma
Yumin Wang, Shiqian Liu, Yan Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
Neelum Aziz Yousafzai, Qiyin Zhou, Wenxia Xu, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 5
Open Access | Times Cited: 51
A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)
Huachao Huang, Weili Kong, Maxime Jean, et al.
Nucleic Acids Research (2019) Vol. 47, Iss. 14, pp. 7333-7347
Open Access | Times Cited: 45
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
Anmi Jose, Gautham G. Shenoy, Gabriel Rodrigues, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2121-2121
Open Access | Times Cited: 37
MicroRNA let-7i Inhibits Histone Lysine Demethylase KDM5B to Halt Esophageal Cancer Progression
Yang Yang, Wenhua Li, Bochong Wei, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 846-861
Open Access | Times Cited: 36
The Role of Histone Lysine Methylation in the Response of Mammalian Cells to Ionizing Radiation
Elena Di Nisio, Giuseppe Lupo, Valerio Licursi, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 30
Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
Ramhari Kumbhar, Anthony Sanchez, Jullian Perren, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 7
Open Access | Times Cited: 29
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 12
Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B)
Bing Zhao, Qianqian Liang, Hongmei Ren, et al.
European Journal of Medicinal Chemistry (2020) Vol. 192, pp. 112161-112161
Closed Access | Times Cited: 32
Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu, Ming-Jie Huang, Jia–Wen Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112760-112760
Closed Access | Times Cited: 30
Glutamine, Serine and Glycine at Increasing Concentrations Regulate Cisplatin Sensitivity in Gastric Cancer by Posttranslational Modifications of KDM4A
Junhao Fu, Yuqi Ni, Yuqing Hu, et al.
Molecular Carcinogenesis (2025)
Open Access
Lysine demethylases and cancer.
Tomáš Eckschlager, Aleš Vícha, Daniela Frolikova
Pathology - Research and Practice (2025) Vol. 271, pp. 156011-156011
Closed Access
Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma
Lijie Li, Huafeng Shou, Qianqian Wang, et al.
Gene (2019) Vol. 694, pp. 76-82
Closed Access | Times Cited: 28
KDM5B regulates the PTEN/PI3K/Akt pathway to increase sorafenib-resistance in hepatocellular carcinoma
Jia Liu, Chunsheng Nie
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 840-849
Closed Access | Times Cited: 14
Targeting histone demethylases as a potential cancer therapy (Review)
Wenfei Diao, Jiabin Zheng, Yong Li, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Closed Access | Times Cited: 13
Jumonji C Demethylases in Cellular Senescence
Kelly E. Leon, Katherine M. Aird
Genes (2019) Vol. 10, Iss. 1, pp. 33-33
Open Access | Times Cited: 20
<p>Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer</p>
Xiaoya Zhao, Jianfei Fu, Wanfen Tang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 4833-4842
Open Access | Times Cited: 19
Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B
Bingluo Zhou, Yiran Zhu, Wenxia Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top